WHITEFISH, MT / September 4, 2014 / Affinor Growers Inc. (OTC: RSSFF)(CSE: AFI), a grower of high quality food crops like romaine lettuce, spinach, strawberries, as well as high quality medical marijuana, recently announced the addition of former MedBox Inc. (OTC: MDBX) CEO Dr. Bruce Bedrick as a consultant. Leveraging his experience at MedBox and Kind Clinics Medical Marijuana Dispensaries, Dr. Bedrick will be tasked with expanding the company’s footprint within the agricultural industry.
"Dr. Bedrick is a dynamic leader and achieves outstanding results in challenging environments," said Affinor Growers Inc. President & CEO Sebastien Plouffe. "He has maintained and continues to build strong and loyal relationships with professionals and colleagues across multiple industry sectors. Bruce is definitely a huge addition for Affinor and I’m proud and honored that he joins our team."
Under the consulting agreement, Dr. Bedrick will be primarily focused on applying his business skillset and advice on expanding the licensing opportunities for the company’s patented vertical growing technology throughout the U.S. and Mexico. Dr. Bedrick’s professional acumen, extensive contacts, and worldwide notoriety should help him achieve these objectives and ultimately improve shareholder value.
Affinor’s proprietary technologies control precise combinations of light, temperature, water, and nutrients to create specific growing conditions that result in optimum crop production, product quality, and shelf life. According to the company, no current growing methods compare to its software-driven, automation technology that results in Grade A1 mechanically pollinated strawberries.
In addition to pursuing licensing opportunities, management has acquired farmland in Canada and intends to build a strawberry facility within the next couple quarters. Strawberries, lettuce, and other crops are in high demand within Canada due to a lack of domestic suppliers, yielding an opportunity for investors.
Investors in the marijuana space may want to take a closer look at the stock given its unique diversification into other cash crops, as well as its patented technology that could offer near-term licensing opportunities. The addition of Dr. Bedrick could accelerate these plans over the coming quarters and ultimately unlock significant shareholder value over both the short- and long-term.
Disclaimer:
Except for the historical information presented herein, matters
discussed in this release contain forward-looking statements that are
subject to certain risks and uncertainties that could cause actual
results to differ materially from any future results, performance or
achievements expressed or implied by such statements. Emerging Growth
LLC is not registered with any financial or securities regulatory
authority, and does not provide nor claims to provide investment advice
or recommendations to readers of this release. Emerging Growth LLC may
from time to time have a position in the securities mentioned herein and
may increase or decrease such positions without notice. For making
specific investment decisions, readers should seek their own advice.
Emerging Growth LLC may be compensated for its services in the form of
cash-based compensation or equity securities in the companies it writes
about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/
SOURCE: Emerging Growth LLC